Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schattenberg

Showing results (81-90 of 333) with videos related to

Pageof 34
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 28, 2012
Adding pegylated interferon to a current nucleos(t)ide therapy leads to HBsAg seroconversion in a subgroup of patients with chronic hepatitis BJens M Kittner, Martin F Sprinzl, Annette Grambihler, et al.
Clinical and Translational Medicine|September 14, 2022
Hepatic interleukin-1 receptor type 1 signalling regulates insulin sensitivity in the early phases of nonalcoholic fatty liver diseaseNadine Gehrke, Lea J Hofmann, Beate K Straub, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|December 2, 2017
Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligationNadine Gehrke, Michael Nagel, Beate K Straub, et al.
Hepatology Communications|October 4, 2022
A higher FIB-4 index is associated with an increased incidence of renal failure in the general populationEva Maria Schleicher, Simon Johannes Gairing, Peter Robert Galle, et al.
Health and Quality of Life Outcomes|January 15, 2020
Impact of acute-on-chronic liver failure and decompensated liver cirrhosis on psychosocial burden and quality of life of patients and their close relativesMichael Nagel, Christian Labenz, Marcus A Wörns, et al.
Hepatology (Baltimore, Md.)|December 24, 2005
JNK1 but not JNK2 promotes the development of steatohepatitis in miceJörn M Schattenberg, Rajat Singh, Yongjun Wang, et al.
Zeitschrift Fur Gastroenterologie|January 15, 2014
[Drug-induced liver injury with an autoimmune phenotype following anti-TNF Therapy - presentation of cases and review of literature]S Rösner, A Schad, J Kittner, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 17, 2023
Higher scores in the Clinical Frailty Scale are associated with covert and overt hepatic encephalopathy in patients with cirrhosisEva Maria Schleicher, Leonard Kaps, Jörn M Schattenberg, et al.
Diabetes, Obesity & Metabolism|May 3, 2024
The sclerotic component of metabolic syndrome: Fibroblast activities may be the central common denominator driving organ function loss and deathAlexander Lynge Reese-Petersen, Signe Holm Nielsen, Jannie Marie Bülow Sand, et al.
Journal of Hepatology|January 18, 2024
Inequities in primary liver cancer in Europe: The state of playLoreta A Kondili, Jeffrey V Lazarus, Peter Jepsen, et al.
Pageof 34

Showing results (81-90 of 333) with videos related to

Sort By:
Pageof 34
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 28, 2012
Adding pegylated interferon to a current nucleos(t)ide therapy leads to HBsAg seroconversion in a subgroup of patients with chronic hepatitis BJens M Kittner, Martin F Sprinzl, Annette Grambihler, et al.
Clinical and Translational Medicine|September 14, 2022
Hepatic interleukin-1 receptor type 1 signalling regulates insulin sensitivity in the early phases of nonalcoholic fatty liver diseaseNadine Gehrke, Lea J Hofmann, Beate K Straub, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|December 2, 2017
Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligationNadine Gehrke, Michael Nagel, Beate K Straub, et al.
Hepatology Communications|October 4, 2022
A higher FIB-4 index is associated with an increased incidence of renal failure in the general populationEva Maria Schleicher, Simon Johannes Gairing, Peter Robert Galle, et al.
Health and Quality of Life Outcomes|January 15, 2020
Impact of acute-on-chronic liver failure and decompensated liver cirrhosis on psychosocial burden and quality of life of patients and their close relativesMichael Nagel, Christian Labenz, Marcus A Wörns, et al.
Hepatology (Baltimore, Md.)|December 24, 2005
JNK1 but not JNK2 promotes the development of steatohepatitis in miceJörn M Schattenberg, Rajat Singh, Yongjun Wang, et al.
Zeitschrift Fur Gastroenterologie|January 15, 2014
[Drug-induced liver injury with an autoimmune phenotype following anti-TNF Therapy - presentation of cases and review of literature]S Rösner, A Schad, J Kittner, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 17, 2023
Higher scores in the Clinical Frailty Scale are associated with covert and overt hepatic encephalopathy in patients with cirrhosisEva Maria Schleicher, Leonard Kaps, Jörn M Schattenberg, et al.
Diabetes, Obesity & Metabolism|May 3, 2024
The sclerotic component of metabolic syndrome: Fibroblast activities may be the central common denominator driving organ function loss and deathAlexander Lynge Reese-Petersen, Signe Holm Nielsen, Jannie Marie Bülow Sand, et al.
Journal of Hepatology|January 18, 2024
Inequities in primary liver cancer in Europe: The state of playLoreta A Kondili, Jeffrey V Lazarus, Peter Jepsen, et al.
Pageof 34